Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes - Wikidata - awgldk - TriplyDB

Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes

Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes

http://www.wikidata.org/entity/Q24800992

about

Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital Candida infections of the genitourinary tract.Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital.Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists a Genital mycotic infections in patients with diabetes.Interactions of Candida albicans with host epithelial surfaces Phenotypic Detection of Genitourinary Candidiasis among Sexually Transmitted Disease Clinic Attendees in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria Hosting infection: experimental models to assay Candida virulence Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes Antifungal Susceptibility Patterns of Vulvovaginal Candida species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda.A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013)Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA Vaginal microbiota of women with frequent vulvovaginal candidiasis.Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factor Estrogen treatment predisposes to severe and persistent vaginal candidiasis in diabetic mice.A novel diabetic murine model of Candida albicans-induced mucosal inflammation and proliferation.Skin signs in diabetes mellitus.Dapagliflozin: a review on efficacy, clinical effectiveness and safety.Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism.Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia.Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).Healthcare costs of urinary tract infections and genital mycotic infections among patients with type 2 diabetes mellitus initiated on canagliflozin: a retrospective cohort study.Cutaneous Manifestations of Diabetes Mellitus: A Review.High glucose-mediated overexpression of ICAM-1 in human vaginal epithelial cells increases adhesion of Candida albicans.Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract.Development of a multiplex assay to measure the effects of shipping and storage conditions on the quality of RNA used in molecular assays for detection of viral haemorrhagic septicemia virus.Understanding Vulvovaginal Candidiasis Through a Community Genomics Approach

P2860

Q26864336-C3442F67-A461-4757-8418-8F59E340B690 Q33589734-590C55AC-DF02-4FEF-92F2-B0EA2818CE82 Q33666272-2A286F20-7214-47AE-B797-543563D4F008 Q33825621-8F3509AB-3983-4B54-AF57-EF9F7DD56D41 Q33839533-99842EF0-31C9-423A-A3DA-070A63112E36 Q34269717-A500593D-3B0A-499A-AA09-35D8391B6396 Q34349532-FA6903E8-D8A0-449D-B3CD-79708DA7EE22 Q34380009-1FB2E0CE-6F7E-42D8-AACF-3314204642AD Q35625873-8DA2AF25-747E-4D94-A7F4-EFB0AF9F2D8B Q35659934-1E70FCFA-EC16-479B-A076-2A5E72D34B9D Q35780861-B9BF79F9-56CC-4D05-9ABB-43D4417124F3 Q35848519-FFC01994-0C1A-418C-B4F0-7010F206FEB7 Q35903282-4E983A9C-CEEC-49C5-9EDD-E0491C2C5CB4 Q36743194-E551857E-1488-479D-BE1F-635B2489B4FC Q36877951-4B583057-C522-440C-BA97-F7B4CA7F9C55 Q37274301-BFD3976E-EC0D-4E77-AD9D-48B5A9BB06F7 Q37333450-CD954D88-CEA1-42FA-B6C6-0FC48AA00FDA Q37544379-64C95F57-1DA0-467D-9813-85B25E2D5651 Q37562111-E6BC6EB9-30C9-4CCA-BC0A-D7D4DC10A663 Q37622173-7ABA0FDD-6B35-4808-A051-0BC3EABA8AB1 Q37986093-58E18C25-EA14-484D-AC58-D9F78B8864B8 Q38057810-0EA9D660-EB1A-4641-A25F-D801B1D0FA36 Q38363105-93D89251-EB92-4492-B216-3B1B7E0FA12E Q38696236-30A253B7-C928-4DD5-A0F1-5076936638DB Q38827140-18F91AE1-598B-498D-9696-89D17F43E767 Q38873457-1E7830C3-1863-43B0-8287-4FC2594DA981 Q39035805-39E674E1-8F3D-4357-8263-2AA06E2335E9 Q39202664-D8FD92C7-11D7-4415-9C3D-2132427AF294 Q39218289-5BD0126B-90E2-4791-BA6E-83E6C1B0FE29 Q41997111-E7290028-BDC7-492E-9C87-32FF30D3FF73 Q42054944-9F5AEF35-FEFB-4756-905E-0747CBF2DAFC Q42187029-67CFB3AE-EB65-4342-985F-75CBE639CBFF Q57233691-7E0A7AE9-728B-42F9-817D-4C859AF6B57C

P2860

Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes

http://www.wikidata.org/entity/Q24800992

description

2002 nî lūn-bûn

@nan

2002 թուականին հրատարակուած գիտական յօդուած

@hyw

2002 թվականին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@ast

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@en

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@nl

type

label

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@ast

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@en

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@nl

prefLabel

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@ast

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@en

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@nl

P1433

Q24800992-D6001E2D-8178-4243-A4DF-69D3E1B005CF

P1476

Q24800992-4C917C4D-33E5-4579-B36F-60F19847C9AB

P2093

Q24800992-2D6971EB-FE0D-49C3-A9CB-54E74ED5BED0

Q24800992-D0140E40-6245-4B16-ACF8-23EA6A514D39

Q24800992-FDD7D49A-68E6-4118-BDC3-256BB4754F92

P2860

Q24800992-034050DE-6F71-479A-969E-DF82586F54ED

Q24800992-0F8152AB-FAEC-40BC-B967-172A12F3707C

Q24800992-1E8C183E-F13D-4EB3-BF7A-3A3FB018C52C

Q24800992-26F0474E-91D8-4BCC-B809-2B0243447D9E

Q24800992-2A285F78-3A51-4CEF-AD65-229200119096

Q24800992-36A8C105-5F76-49AB-9C43-1912036E6413

Q24800992-3748E5A6-3588-4CC8-8723-7D5AD38265B6

Q24800992-3A618277-A737-46BF-9915-A6885C114C0C

Q24800992-4B806223-B4E7-4832-9BB8-9A3A4647F3C7

Q24800992-91B5516B-6DA9-48E8-B59E-5B8AE733DA37

P2888

Q24800992-546F73FA-57FB-4D94-B8F3-D7D5F72C1CA7

P304

Q24800992-AAE8578D-6605-4270-AA43-E1A8F82F2553

P31

Q24800992-3750CE35-68E1-4FCB-88F7-D5537F93785F

P3181

Q24800992-7B413294-7147-4884-A64A-A7D2DA0105D0

P356

Q24800992-843C31EC-29A4-4E44-919C-B0242AB3C821

P407

Q24800992-63E98089-17D6-4598-8804-64541156FAA6

P433

Q24800992-6D4F4524-60D2-4500-9B9F-643CC99BB8D2

P478

Q24800992-996A54E1-DBE2-4C95-A37A-3102263FB83A

P50

Q24800992-8C9A67C9-A767-4E32-B536-16AA9D76DAF2

P577

Q24800992-F8CA4AB4-6FCD-459E-B9EC-C0A84BDFB46D

P5875

Q24800992-29E31BF6-4C4D-4213-AB48-DB7D43707FF7

P6179

Q24800992-F2BC6A69-FA8F-4EF6-8820-807EBA0A67F5

P698

Q24800992-028C8351-D9AE-493D-BEDF-609109BE733C

P921

Q24800992-B55DE97D-4F0D-47B1-92D4-1CC7BC7B848C

Q24800992-E57DB815-FCDE-42DC-8AAF-B3E48C5CF901

P932

Q24800992-B1542827-FCEF-4165-A58D-95C1048BDA96

P3181

P356

P1433

BMC Infectious Diseases

P1476

Prevalence and risk factors fo ...... ith type 1 and type 2 diabetes

@en

P2093

Ella M de Leon

http://www.w3.org/2001/XMLSchema#string

Jack D Sobel

http://www.w3.org/2001/XMLSchema#string

Scott J Jacober

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis.

Risk factors for Candida vulvovaginitis.

Is candidiasis the true cause of vulvovaginal irritation in women with diabetes mellitus?

Vaginal infections in adult women.

Infection and diabetes: the case for glucose control.

Candidal vulvovaginitis.

Treatment of vulvovaginal candidiasis in patients with diabetes.

High vaginal swab(HVS), routine microscopy and culture sensitivity in diabetic and non diabetic, a comparative retrospective study of five years.

The incidence of Candida albicans in the vagina of "healthy young women". How often do they have symptoms? Possible etiological factors.

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4758906

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2334-2-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11524576

http://www.w3.org/2001/XMLSchema#string

P6179

1028468039

http://www.w3.org/2001/XMLSchema#string

P698

11835694

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

type-2 diabetes

P932

65518

http://www.w3.org/2001/XMLSchema#string